Rituximab Biosimilars Market: Expanding Access to Essential Cancer...

agregó una foto Health

2026-07-14 08:54:18 -

Market Overview The Rituximab Biosimilars Market is a rapidly growing sector, driven by the need for more affordable and accessible versions of this essential biologic therapy. Rituximab is a monoclonal antibody used to treat a range of hematological malignancies and autoimmune diseases. The patent expiration of the originator drug has opened the door for biosimilars, which are highly similar...

0 Commentarios 0 Acciones 68 Views 0 Vista previa